BioIVT Acquires Cypex, a Leading Manufacturer of Drug-Metabolizing Enzymes
Westbury, NY – August 8, 2022 – BioIVT, a leading provider of
biospecimens, research models and services for drug and diagnostic
development, today announced that it has acquired Cypex, a renowned
manufacturer of recombinant xenobiotic metabolizing enzymes, based in
Dundee, Scotland. Cypex’s extensive enzyme portfolio covers a wide range
of proteins involved in drug metabolism.
More info >> |